マイクロバイオームシーケンスサービス市場規模、シェア、動向分析レポート、技術別（合成によるシーケンス、ライゲーションによるシーケンス、サンガーシーケンス）、用途別、最終用途別、地域別、セグメント予測、2023～2030年

マイクロバイオームシーケンスサービス市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界のマイクロバイオームシーケンスサービス市場規模は、2030年までに31億米ドルに達すると予測されています。

世界の投資の増加やゲノム研究の増加により、2023年から2030年にかけてCAGR10.9%で市場が拡大すると予測されています。例えば、2022年10月、デンマークのマイクロバイオーム調査会社であるClinical Microbiomics社は、ベンチャーキャピタルのSeventure Partners社が同社に1000万ユーロ（約970万米ドル）を投資したと発表しました。この資金は、クリニカル・マイクロバイオミクス社がシステムバイオロジーとマイクロバイオーム・プロファイリングプラットフォームを進化させるとともに、マルチオミクスデータ統合のためのサービス提供範囲を広げ、米国を皮切りに国際的に展開するために使われる予定です。研究開発におけるゲノムの取り組みが多いため、マイクロバイオームシーケンスサービスの市場は拡大しています。

マイクロバイオームが人の健康に大きな影響を与えるという証拠が増える中、マイクロバイオームシーケンスに関する調査は近年大きく進展しています。シーケンサー技術の大幅な向上とサービスコストの大幅な低下により、ヒトの体内や体外に存在する様々な微生物を調べる研究が容易に行えるようになりました。また、ヒトの体内微生物がヒトの生理機能にどのような影響を与えるかについての研究が進み、がん、精神疾患、自己免疫疾患、感染症など、さまざまな疾患に対する新しい治療法や予防法の開発につながる大きな可能性を持っています。このようなマイクロバイオームに関する研究の高まりは、マイクロバイオームシーケンスサービスの需要を促進すると予想されます。

COVID-19のパンデミックは、マイクロバイオームシーケンスサービスの市場に好影響を及ぼしています。マイクロバイオームシーケンスは、主に感染症やがんの分野で採用されています。ウイルスの存在やCOVID-19に対する宿主の反応は、RNAシーケンシングによって判明する可能性があります。そのため、2020年以降の発展を支える主な要因の1つは、COVID-19のパンデミック時にマイクロバイオームシーケンスツールの導入が進んだことです。

さらに、政府が業界関係者と提携して広範なウイルス研究を行ったことも、パンデミックの際にマイクロバイオームシーケンスに対する高い需要を後押ししました。例えば、英国は2020年3月、COVID-19陽性患者のサンプルの迅速かつ包括的、網羅的なシーケンス解析を促進するために、ゲノムシーケンスパートナーシップを設立しました。このネットワークは、このウイルスの陽性患者サンプルすべての配列を決定することを目指しています。オックスフォード・ナノポアは、英国でこのイニシアチブに取り組むチームを支援することを嬉しく思います。

マイクロバイオームシーケンスサービス市場レポートハイライト：

• 合成別シーケンスセグメントは、2022年に57.5%の最大シェアを占め、予測期間中に有利なCAGRで拡大すると予想されます。これは、合成によるシーケンス法が、数百万個のアンプリコンの同時シーケンスを可能にする高度な並列性を持つため、細菌群集の研究への関心が大きく高まった結果です。
• 用途別では、2022年の市場で消化器疾患分野が54.0％と最大のシェアを占めています。これは、消化器疾患の発生率が高いこと、腸内細菌叢やプロバイオティクスの使用に関連する意識が高まっていることに起因していると考えられます。
• 最終用途別では、学術研究機関セグメントが2022年に43.3%の最大シェアを占めました。研究機関や学術機関において、タンパク質、および低分子分析のためのマイクロバイオームシーケンスサービスが広く適用されていることが、このセグメントの高い市場シェアに寄与しています。
• 北米は2022年に47.85%の最大市場シェアを獲得しました。この地域別市場シェアの高さは、マイクロバイオームシーケンスサービスにおける極めて高度な技術やシステムの利用が増加したことや、ゲノム研究において技術開発が進んだことが大きな要因となっています。さらに、北米の市場は、マイクロバイオームシーケンスサービスにおける技術的に高度な手法やプラットフォームの採用の増加、およびゲノム研究においてなされた技術の進歩により、より急速に発展すると予想されます。

目次

第1章 調査手法と範囲

• 情報調達
• 情報またはデータ分析
• 市場範囲とセグメントの定義
• 市場モデル
  • 企業市場シェア別の市場調査
  • 地域分析

第2章 エグゼクティブサマリー

• 市場スナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

• 市場セグメンテーションと範囲
• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し
• 市場力学
  • 市場促進要因の分析
    • ゲノム調査の増加とマイクロバイオーム配列決定の用途の拡大
    • 次世代シーケンシングの採用への投資の増加
    • 慢性疾患の有病率の上昇とマイクロバイオーム配列決定の必要性
  • 市場抑制要因分析
    • マイクロバイオーム配列データ分析の専門知識と熟練した専門家の不足
• 業界分析ツール
  • SWOT分析;要因別（政治・法律、経済・技術）
  • ポーターのファイブフォース分析
  • 普及と成長の見通しマッピング、2022年
• COVID-19感染症の影響分析

第4章 マイクロバイオームシーケンスサービス市場：テクノロジービジネス分析

• マイクロバイオームシーケンスサービス市場：テクノロジー市場シェア分析
• 技術別
• 合成別配列決定
• ライゲーション別配列決定
• サンガー配列決定
• その他

第5章 マイクロバイオームシーケンスサービス市場：用途ビジネス分析

• マイクロバイオームシーケンスサービス市場：用途市場シェア分析
• 用途別
• 自己免疫疾患
• がん
• 胃腸障害
• その他の用途

第6章 マイクロバイオームシーケンスサービス市場：エンドユーザービジネス分析

• マイクロバイオームシーケンスサービス市場：エンドユーザー市場シェア分析
• 最終用途別
• 製薬およびバイオテクノロジー企業
• 学術調査機関
• 他のエンドユーザー

第7章 マイクロバイオームシーケンスサービス市場：地域ビジネス分析

• 地域別マイクロバイオームシーケンスサービス市場シェア、2022年および2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• MEA
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 会社の分類
• 戦略マッピング
• 企業プロファイル・一覧表
  • Microbiome Insights Inc.
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • Baseclear BV
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • Clinical-Microbiomics A/S
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • Merieux NutriSciences Corporation
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • MR DNA
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • Metabiomics Corp.
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • Rancho BioSciences
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • Second Genome
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • Zymo Research Corporation
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み
  • uBiome, Inc.
    • 概要
    • 財務実績（純収益/売上高/EBITDA/売上総利益）
    • テクノロジーのベンチマーク
    • 戦略的取り組み

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 4 Global microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 5 Global microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 6 Global microbiome sequencing services market, by region, 2018 - 2030 (USD million)
• Table 7 North America microbiome sequencing services market, by country, 2018 - 2030 (USD million)
• Table 8 North America microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 9 North America microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 10 North America microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 11 U.S. microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 12 U.S. microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 13 U.S. microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 14 Canada microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 15 Canada microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 16 Canada microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 17 Europe microbiome sequencing services market, by country, 2018 - 2030 (USD million)
• Table 18 Europe microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 19 Europe microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 20 Europe microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 21 UK microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 22 UK microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 23 UK microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 24 Germany microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 25 Germany microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 26 Germany microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 27 France microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 28 France microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 29 France microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 30 Italy microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 31 Italy microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 32 Italy microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 33 Spain microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 34 Spain microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 35 Spain microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 36 Denmark microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 37 Denmark microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 38 Denmark microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 39 Sweden microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 40 Sweden microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 41 Sweden microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 42 Norway microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 43 Norway microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 44 Norway microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 45 Asia Pacific microbiome sequencing services market, by country, 2018 - 2030 (USD million)
• Table 46 Asia Pacific microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 47 Asia Pacific microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 48 Asia Pacific microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 49 Japan microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 50 Japan microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 51 Japan microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 52 China microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 53 China microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 54 China microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 55 India microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 56 India microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 57 India microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 58 Australia microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 59 Australia microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 60 Australia microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 61 Thailand microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 62 Thailand microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 63 Thailand microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 64 South Korea microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 65 South Korea microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 66 South Korea microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 67 Latin America microbiome sequencing services market, by country, 2018 - 2030 (USD million)
• Table 68 Latin America microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 69 Latin America microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 70 Latin America microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 71 Brazil microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 72 Brazil microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 73 Brazil microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 74 Mexico microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 75 Mexico microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 76 Mexico microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 77 Argentina microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 78 Argentina microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 79 Argentina microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 80 Middle East & Africa microbiome sequencing services market, by country, 2018 - 2030 (USD million)
• Table 81 Middle East & Africa microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 82 Middle East & Africa microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 83 Middle East & Africa microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 84 South Africa microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 85 South Africa microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 86 South Africa microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 87 Saudi Arabia microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 88 Saudi Arabia microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 89 Saudi Arabia microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 90 UAE microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 91 UAE microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 92 UAE microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 93 Kuwait microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
• Table 94 Kuwait microbiome sequencing services market, by application, 2018 - 2030 (USD million)
• Table 95 Kuwait microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
• Table 96 Participant's overview
• Table 97 Financial performance
• Table 98 Key companies undergoing expansions
• Table 99 Key companies undergoing acquisitions
• Table 100 Key companies undergoing collaborations
• Table 101 Key companies launching new products/services
• Table 102 Key companies undertaking other strategies

List of Figures

• Fig. 1 Microbiome sequencing services market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Related/ancillary market outlook
• Fig. 14 Microbiome sequencing services - Industry value chain analysis
• Fig. 15 Microbiome sequencing services market driver analysis
• Fig. 16 Microbiome sequencing services market restraint analysis
• Fig. 17 Microbiome sequencing services market: Porter's analysis
• Fig. 18 Microbiome sequencing services market: PESTLE analysis
• Fig. 19 Microbiome sequencing services market: Technology outlook and key takeaways
• Fig. 20 Microbiome sequencing services market: Technology market share analysis, 2022 - 2030
• Fig. 21 Global sequencing by synthesis market, 2018 - 2030 (USD million)
• Fig. 22 Global sequencing by ligation market, 2018 - 2030 (USD million)
• Fig. 23 Global sanger sequencing market, 2018 - 2030 (USD million)
• Fig. 24 Global other technology market, 2018 - 2030 (USD million)
• Fig. 25 Microbiome sequencing services market: Application outlook and key takeaways
• Fig. 26 Microbiome sequencing services market: Application market share analysis, 2022 - 2030
• Fig. 27 Global autoimmune disorder market, 2018 - 2030 (USD million)
• Fig. 28 Global cancer market, 2018 - 2030 (USD million)
• Fig. 29 Global gastrointestinal disorders market, 2018 - 2030 (USD million)
• Fig. 30 Global others applications market, 2018 - 2030 (USD million)
• Fig. 31 Microbiome sequencing services market: End-user outlook and key takeaways
• Fig. 32 Microbiome sequencing services market: End-user market share analysis, 2022 - 2030
• Fig. 33 Global Pharmaceutical & Biotechnology Companies market, 2018 - 2030 (USD million)
• Fig. 34 Global Academic research Institutes market, 2018 - 2030 (USD million)
• Fig. 35 Global other end-user market, 2018 - 2030 (USD million)
• Fig. 36 Regional marketplace: Key takeaways
• Fig. 37 Regional marketplace: Key takeaways
• Fig. 38 North America microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 39 U.S. key country dynamics
• Fig. 40 U.S. microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 41 Canada key country dynamics
• Fig. 42 Canada microbiome sequencing services market, 2018 - 2030 (USD million)
• Fig. 43 Europe microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 44 UK key country dynamics
• Fig. 45 UK microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 46 Germany key country dynamics
• Fig. 47 Germany microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 48 France key country dynamics
• Fig. 49 France microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 50 Italy key country dynamics
• Fig. 51 Italy microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 52 Spain key country dynamics
• Fig. 53 Spain microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 54 Denmark key country dynamics
• Fig. 55 Denmark microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 56 Sweden key country dynamics
• Fig. 57 Sweden microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 58 Norway key country dynamics
• Fig. 59 Norway microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 60 Asia Pacific microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 61 Japan key country dynamics
• Fig. 62 Japan microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 63 China key country dynamics
• Fig. 64 China microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 65 India key country dynamics
• Fig. 66 India microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 67 Australia key country dynamics
• Fig. 68 Australia microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 69 Thailand key country dynamics
• Fig. 70 Thailand microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 71 South Korea key country dynamics
• Fig. 72 South Korea microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 73 Latin America microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 74 Brazil key country dynamics
• Fig. 75 Brazil microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 76 Mexico key country dynamics
• Fig. 77 Mexico microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 78 Argentina key country dynamics
• Fig. 79 Argentina microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 80 MEA microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 81 South Africa key country dynamics
• Fig. 82 South Africa microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 83 Saudi Arabia key country dynamics
• Fig. 84 Saudi Arabia microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 85 UAE key country dynamics
• Fig. 86 UAE microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 87 Kuwait key country dynamics
• Fig. 88 Kuwait microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 89 Key company categorization
• Fig. 90 Company market positioning
• Fig. 91 Market participant categorization
• Fig. 92 Strategy framework

Microbiome Sequencing Services Market Growth & Trends:

The global microbiome sequencing services market size is projected to reach USD 3.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.9% from 2023 to 2030, as a result of rising investment and an increase in genomic research globally. For instance, in October 2022, Danish microbiome research comp1any, Clinical Microbiomics announced that venture capital firm Seventure Partners had invested €10 million ($9.7 million) in the company. The funds will be used by Clinical Microbiomics to advance the systems biology and microbiome profiling platforms, as well as to broaden the scope of their service offerings for multi-omics data integration and extend their reach internationally, starting with the US. Due to a large number of genomic initiatives for research and development, the market for microbiome sequencing services is growing.

With growing evidence that microbiomes have a significant effect on human health, the research on microbiome sequencing has advanced considerably in recent years. Studies investigating the variety of microbes that exist on and inside human bodies are now possible easily since there have been major improvements in sequencing technologies and significant declines in the costs of services. Furthermore, growing research on how the human body's microbiome influences certain aspects of human physiology provides enormous potential for the development of novel treatments and preventative measures for a wide range of diseases including cancer, mental health disorders, autoimmune conditions, and infectious diseases. This growing research on the microbiome is expected to drive the demand for microbiome sequencing services.

The COVID-19 pandemic has had positive effects on the market for microbiome sequencing services. Microbiome sequencing is mainly employed in the fields of infectious disease and cancer. The existence of the virus and the host's reaction to COVID-19 may be determined through RNA sequencing. Therefore, one of the key factors supporting its development in 2020 and beyond was the increasing adoption of microbiome sequencing tools during the COVID-19 pandemic.

Moreover,the government's partnerships with industry participants for extensive virus research also fueled the pandemic's high demand for microbiome sequencing. For instance, the UK established a genome sequencing partnership in March 2020 to facilitate rapid, comprehensive, and exhaustive sequencing analysis of samples from patients who tested positive for COVID-19. The network seeks to sequence every positive patient sample for the virus. Oxford Nanopore is pleased to assist the teams working on this initiative in the UK

Microbiome Sequencing Services Market Report Highlights:

• The sequencing by synthesis segment held the largest share of 57.5% in 2022 and is expected to expand at a lucrative CAGR during the forecast period. This is a result of the sequencing by synthesis method's highly parallel nature, which enables the simultaneous sequencing of millions of amplicons, which has greatly increased interest in the study of bacterial communities

• By application, the gastrointestinal disorders segment accounted for the largest share of 54.0% in the market in 2022. This can be attributed to the high incidences of gastrointestinal disorders and growing awareness related to the gut microflora and the use of probiotics

• By end-user, the academic research institutes segment held the largest share of 43.3% in 2022. The widespread application of microbiome sequencing services for protein, as well as small molecule analysis in research institutions and academics, contributes to the segment's high market share

• North America held the largest market share of 47.85% in 2022. The high regional market share is largely due to the rise in the usage of extremely sophisticated techniques and systems in microbiome sequencing services and the technological developments made in genomic research studies. Furthermore, the market in North America is expected to develop more rapidly due to the increase in the adoption of technologically advanced methods and platforms in the microbiome sequencing services and advances in technology made in genomic research studies

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model
  • 1.4.1. Market Study, By Company Market Share
  • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Increased genomic research and expanded uses for microbiome sequencing
    • 3.3.1.2. Increasing investments in next-generation sequencing adoption
    • 3.3.1.3. Rising prevalence of chronic diseases and need for microbiome sequencing
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Lack of expertise and skilled professionals for microbiome sequencing data analysis
• 3.4. Industry Analysis Tools
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.4.2. Porter's Five Forces Analysis
  • 3.4.3. Penetration and Growth Prospect Mapping, 2022
• 3.5. COVID-19 Impact Analysis

Chapter 4. Microbiome Sequencing Services Market: Technology Business Analysis

• 4.1. Microbiome Sequencing Services Market: Technology Market Share Analysis
• 4.2. Microbiome Sequencing Services Market Estimates & Forecast, By Technology (USD Million)
• 4.3. Sequencing by synthesis
  • 4.3.1. Global Sequencing by synthesis Market, 2018 - 2030 (USD Million)
• 4.4. Sequencing by ligation
  • 4.4.1. Global sequencing by ligation Market, 2018 - 2030 (USD Million)
• 4.5. Sanger sequencing
  • 4.5.1. Global sanger sequencing Market, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Global other technology Market, 2018 - 2030 (USD Million)

Chapter 5. Microbiome Sequencing Services Market: Application Business Analysis

• 5.1. Microbiome Sequencing Services Market: Application Market Share Analysis
• 5.2. Microbiome Sequencing Services Market Estimates & Forecast, By Application (USD Million)
• 5.3. Autoimmune Disorder
  • 5.3.1. Global autoimmune disorder Market, 2018 - 2030 (USD Million)
• 5.4. Cancer
  • 5.4.1. Global cancer Market, 2018 - 2030 (USD Million)
• 5.5. Gastrointestinal disorders
  • 5.5.1. Global gastrointestinal disorders Market, 2018 - 2030 (USD Million)
• 5.6. Other applications
  • 5.6.1. Global other applications Market, 2018 - 2030 (USD Million)

Chapter 6. Microbiome Sequencing Services Market: End-User Business Analysis

• 6.1. Microbiome Sequencing Services Market: End-User Market Share Analysis
• 6.2. Microbiome Sequencing Services Market Estimates & Forecast, By End-User (USD Million)
• 6.3. Pharmaceutical & Biotechnology Companies
  • 6.3.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 6.4. Academics research institutes
  • 6.4.1. Global academics research institutes Market, 2018 - 2030 (USD Million)
• 6.5. Other end-users
  • 6.5.1. Global other end-users Market, 2018 - 2030 (USD Million)

Chapter 7. Microbiome Sequencing Services Market: Regional Business Analysis

• 7.1. Microbiome Sequencing Services Market Share By Region, 2022 & 2030
• 7.2. North America
  • 7.2.1. North America Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Regulatory Framework
    • 7.2.2.4. U.S. Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Regulatory Framework
    • 7.2.3.4. Canada Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. UK Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Germany Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. France Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Regulatory Framework
    • 7.3.5.4. Italy Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Regulatory Framework
    • 7.3.6.4. Spain Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Competitive Scenario
    • 7.3.7.3. Regulatory Framework
    • 7.3.7.4. Denmark Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Regulatory Framework
    • 7.3.8.4. Sweden Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Regulatory Framework
    • 7.3.9.4. Norway Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Japan Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. China Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. India Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.4.5. Australia
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Australia Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Thailand Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.4.7. South Korea
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. South Korea Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Brazil Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Mexico Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.5.4. Argentina
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Argentina Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. South Africa Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Saudi Arabia Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. UAE Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Kuwait Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Profiles/Listing
  • 8.3.1. Microbiome Insights Inc.
    • 8.3.1.1. Overview
    • 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.1.3. Technology Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Baseclear BV
    • 8.3.2.1. Overview
    • 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.2.3. Technology Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Clinical-Microbiomics A/S
    • 8.3.3.1. Overview
    • 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.3.3. Technology Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Merieux NutriSciences Corporation
    • 8.3.4.1. Overview
    • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.4.3. Technology Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. MR DNA
    • 8.3.5.1. Overview
    • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.5.3. Technology Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Metabiomics Corp.
    • 8.3.6.1. Overview
    • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.6.3. Technology Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Rancho BioSciences
    • 8.3.7.1. Overview
    • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.7.3. Technology Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Second Genome
    • 8.3.8.1. Overview
    • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.8.3. Technology Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Zymo Research Corporation
    • 8.3.9.1. Overview
    • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.9.3. Technology Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. uBiome, Inc.
    • 8.3.10.1. Overview
    • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.10.3. Technology Benchmarking
    • 8.3.10.4. Strategic Initiatives